Tristel Regulatory News (TSTL)

Tristel plc

("Tristel" or the "Company")

Forthcoming Appointment of Dr Holthof as Non-Executive Chairman

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that Dr Bruno Holthof will take over the role of Non-Executive Chairman at the Company's forthcoming Annual General Meeting.

Dr Holthof joined the Board of Tristel in February 2019 as an Independent Non-Executive Director. Having spent ten months familiarising himself with the Company he will take over the position of Non-Executive Chairman from Paul Barnes at the 2019 AGM. Paul Barnes has provided interim cover in the role, after Francisco Soler stepped down in December 2018. Paul Barnes will remain a Non-Executive Director of the Company.

The Board will now begin the search for a third Independent Non-Executive Director to maintain an appropriate balance between executive and non-executive directors as detailed in the QCA guidelines on Board composition.

Paul Swinney, CEO said: "I would like to thank Paul Barnes for his thoughtful stewardship of our Board over the past year. I am delighted that Dr Holthof has agreed to take up the position of Chair, bringing his broad experience of global healthcare to our Company. In the New Year we shall begin a selection process for an additional Independent Non-Executive Director."

Dr Holthof, commented: "As I step up to the Chairman role, my primary focus will be to work with my Board colleagues to ensure the Company continues to deliver upon its strategic goals, whilst safeguarding the unique character of this excellent business. I look forward to the future with great enthusiasm."

The Company's AGM will be held at the Company's premises at Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire CB8 7NY on 17 December 2019 at 10am.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

For further information please contact: